Methylation in the Human Body: How Does It Work and How Can We Assess It?

Methylation is one of the fundamental biochemical processes in the human body and is involved in numerous functions, ranging from metabolism and the synthesis of important biological molecules to the regulation of gene expression.

It involves the transfer of a small chemical group (a methyl group) from one molecule to another. Although this process may appear simple, it forms part of a complex network of metabolic reactions essential for normal cellular function.

The relationship between methylation, nutrition, one-carbon metabolism, and epigenetics is of particular scientific interest. However, it is important to distinguish the broader metabolic process of methylation from DNA methylation, which represents a specific mechanism of epigenetic regulation.

What Is Methylation and Why Is It Important?

Methylation is a biochemical reaction in which a methyl group (–CH₃) is transferred to another molecule by specialized enzymes called methyltransferases.

These reactions are involved in numerous biological processes, including:

• Regulation of gene expression: Methylation of DNA and certain DNA-associated proteins contributes to the regulation of gene activity.
• Nervous system function: Methylation-related metabolic pathways are involved in the synthesis and metabolism of substances that contribute to neurological function.
• Phospholipid metabolism: Methylation reactions participate in the synthesis of certain phospholipids, such as phosphatidylcholine, which is a component of cell membranes.
• Creatine metabolism: Creatine synthesis is a major process that consumes methyl groups.
• Modification of proteins and RNA: Methylation contributes to the regulation of the function and stability of various cellular molecules.

Therefore, methylation is not a single biological function but a set of reactions that help maintain normal cellular activity.

The Methylation Cycle and One-Carbon Metabolism

For methylation reactions to occur, the body requires suitable methyl-group donors and functional metabolic pathways that ensure their availability.

The methionine cycle, which is closely linked to one-carbon metabolism, plays a central role.

Methionine, an essential amino acid, is used to synthesize S-adenosylmethionine (SAM). SAM is one of the most important methyl-group donors in the body.

After transferring its methyl group, SAM is converted into S-adenosylhomocysteine (SAH), which can subsequently be broken down into homocysteine and adenosine.

Homocysteine occupies a critical position in metabolism, as it can:

• Be converted back into methionine through reactions involving folate and vitamin B12 or, in certain tissues, betaine.
• Enter the transsulfuration pathway, contributing to cysteine synthesis through reactions that require vitamin B6.
   

Vitamin B2, choline, and other nutritional and enzymatic factors also participate in these metabolic pathways.

This network's function depends on the availability of essential substrates, enzymatic activity, and the body's overall metabolic state.

The Significance of the SAM/SAH Ratio

SAM provides methyl groups for numerous reactions, while SAH can inhibit certain methyltransferases. For this reason, the SAM/SAH ratio is used as a biochemical indicator of methylation potential.

However, it is important to note that this ratio does not provide a universal measure of the “methylation capacity” of all tissues and cannot, on its own, be used to assess DNA methylation.

The Relationship Between Methylation, DNA, and Epigenetics

DNA methylation is one of the best-studied epigenetic mechanisms.

During this process, specialized enzymes add methyl groups to specific DNA sites, primarily to cytosines at CpG sites, where a cytosine (C) is followed by a guanine (G) in the DNA sequence. Depending on their location within the genome and the cellular context, these modifications can influence gene expression without altering the DNA sequence itself.

The connection with methylation metabolism is direct at the biochemical level: DNA methyltransferases use SAM as a methyl-group donor. However, SAM availability or the SAM/SAH ratio alone does not determine DNA methylation patterns. Numerous additional factors regulate this process, including epigenetic enzyme activity, chromatin structure, and cell type.

Therefore, assessing methylation-related metabolic pathways and directly analyzing DNA methylation represent two distinct laboratory approaches.

Methylation, Health, and Chronic Diseases

One-carbon metabolism supports important cellular functions, and disturbances in associated metabolic pathways may be linked to nutritional deficiencies and certain pathological conditions.

A classic example is elevated homocysteine, which may occur in folate or vitamin B12 deficiency, kidney dysfunction, and other conditions. Elevated homocysteine levels have also been associated with cardiovascular risk, although lowering these levels does not necessarily lead to a corresponding reduction in cardiovascular events.

In parallel, researchers have studied changes in DNA methylation patterns in relation to cardiovascular and metabolic diseases, certain types of cancer, neurodegenerative disorders, and the aging process.

However, it is important to distinguish between these two research approaches. A disturbance in one-carbon metabolism does not necessarily imply a specific epigenetic alteration, while an altered DNA methylation pattern does not, on its own, establish metabolic dysfunction.

The relevant laboratory parameters must always be interpreted in the context of the individual's medical history and overall clinical picture.

Laboratory Assessment of Methylation Metabolism

Laboratory assessment can investigate different aspects of methylation metabolism using conventional biochemical tests, specialized metabolic profiles, and genetic analyses.

These tests do not all provide the same information, and their selection depends on the specific clinical question.

1. Methylation Capacity – Comprehensive Profile
This specialized biochemical profile measures S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), the SAM/SAH ratio, homocysteine, methionine, dimethylglycine (DMG), choline, betaine, and cystathionine.
Together, these parameters provide information about selected stages of the methionine cycle and one-carbon metabolism. It does not directly measure DNA methylation or epigenetic age.

2. Methylation Index – SAM/SAH
This test measures SAM, SAH, and their ratio.
The SAM/SAH ratio indicates methylation potential, as it reflects the relationship between a major methyl-group donor and a metabolite that can inhibit methylation reactions.
Its interpretation depends on the biological sample, the analytical method, and the clinical context, and it does not allow direct assessment of epigenetic status.

3. MethylGenomiX® – Genetic Testing of Methylation-Related Metabolic Pathways
MethylGenomiX® analyzes genetic polymorphisms in genes involved in one-carbon metabolism and related biochemical pathways.
It is available in basic and comprehensive profiles, with the comprehensive profile including the analysis of 70 genetic polymorphisms.
The test provides information about selected genetic variants that may be associated with the function of specific enzymes and metabolic pathways. However, the presence of a polymorphism does not necessarily indicate functional impairment or a clinically significant alteration.
Furthermore, since genetic variants generally remain stable throughout life, the test does not reflect the current metabolic state or DNA methylation patterns.

4. Conventional Laboratory Tests
Depending on medical history and clinical indications, the assessment may be supplemented by measurements of homocysteine, vitamin B12, and folate, as well as a complete blood count to evaluate possible hematological changes associated with nutritional deficiencies. These tests can provide useful information about factors influencing one-carbon metabolism, without directly measuring the overall activity of methylation reactions.

DNA Methylation and Biological Aging

DNA methylation patterns change naturally during development and aging. Some of these changes exhibit relatively predictable characteristics, leading to the development of so-called epigenetic clocks.

Epigenetic clocks are mathematical models that use methylation data from selected CpG sites to estimate epigenetic age or other characteristics associated with biological aging.

Different models may capture different aspects of aging, while epigenetic age does not necessarily correspond to an individual's overall biological age.

Assessing these parameters requires direct analysis of DNA methylation and cannot be done with tests such as SAM/SAH measurements, homocysteine testing, or genetic analysis of polymorphisms in methylation-related pathways.

Although epigenetic age markers have been associated with various health outcomes in population studies, their usefulness for individualized clinical decision-making remains under investigation.

Can We Support Normal Methylation Metabolism?

The normal function of methylation-related metabolic pathways depends on several factors, including the adequate availability of essential nutrients, enzyme function, and overall metabolic status.

Diet provides substances involved in one-carbon metabolism, such as folate, vitamins B12, B6, and B2, choline, betaine, and methionine.

Adequate intake of these nutrients supports the normal function of the relevant metabolic pathways. However, increasing their intake beyond the body's actual requirements does not necessarily improve methylation.

At the same time, regular physical activity, adequate sleep, avoiding smoking, and maintaining metabolic health are important aspects of overall health and healthy aging.

Dietary supplementation may be appropriate when there is a documented deficiency or a specific clinical indication, but it should not be seen as a general way to “enhancing methylation” or reverse epigenetic age.

Conclusion

Methylation is a fundamental biochemical process involved in numerous human bodily functions. One-carbon metabolism, the methionine cycle, and the availability of methyl-group donors shape the biochemical environment in which these reactions take place.

Modern laboratory testing allows the assessment of selected metabolites, nutritional factors, and genetic variants associated with these pathways. However, assessing methylation metabolism does not equal directly measuring DNA methylation or epigenetic age.

The true value of these tests lies in selecting and interpreting them appropriately, based on medical history, available scientific evidence, and the specific clinical question.

References

1. Xing Z, Tu BP. Mechanisms and rationales of SAM homeostasis. Trends Biochem Sci. 2025;50(3):242-254. doi:10.1016/j.tibs.2024.12.009
2. Bortz J, Obeid R. The Shuttling of Methyl Groups Between Folate and Choline Pathways. Nutrients. 2025;17(15):2495. Published 2025 Jul 30. doi:10.3390/nu17152495
3. Bernasocchi T, Mostoslavsky R. Subcellular one carbon metabolism in cancer, aging and epigenetics. Front Epigenet Epigenom. 2024;2:1451971. doi:10.3389/freae.2024.1451971
4. Warner B, Ratner E, Datta A, Lendasse A. A systematic review of phenotypic and epigenetic clocks used for aging and mortality quantification in humans. Aging (Albany NY). 2024 Aug 30;16(17):12414-12427. doi: 10.18632/aging.206098. Epub 2024 Aug 30.
5. Chervova O, et al. Breaking new ground on human health and well being with epigenetic clocks: A systematic review and meta analysis of epigenetic age acceleration associations. Ageing Research Reviews. 2024;101:102552.
6. Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, Li J. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022 Dec 16;7(1):391. doi: 10.1038/s41392-022-01251-0.
7. Mishra S, Raval M, Kachhawaha AS, Tiwari BS, Tiwari AK. Aging: Epigenetic modifications. Prog Mol Biol Transl Sci. 2023;197:171-209. doi: 10.1016/bs.pmbts.2023.02.002. Epub 2023 Mar 13.

At Diagnostiki Athinon, we treat prevention with the seriousness it deserves. This is where science meets personalized care.